MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Avanzanite Bioscience has appointed a new Chief Financial Officer

Spruce Biosciences Reports Long-Term Data Showing Efficacy and Safety of Tralesinidase Alfa in Sanfilippo Syndrome Type B

18 Aug 2025

Spruce Biosciences, Inc. a late-stage biopharmaceutical company focused on developing and...

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

Roche's first respiratory test, powered by TAGS technology, has received FDA clearance for SARS-CoV-2, Influenza A, Influenza B, and RSV

Astellas gets positive CHMP opinion for PADCEV™ and KEYTRUDA® combo in advanced bladder cancer.

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

Nnamdi Njoku Named President of Omnicell

By Omnicell, Inc.
Omnicell, Inc.
01 Jul 2026

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

By Novo Nordisk
Novo Nordisk
01 Jul 2026

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

By Queue
Queue
30 Jun 2026

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

By Avenacy
Avenacy
29 Jun 2026

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

By Johnson & Johnson
Johnson & Johnson
25 Jun 2026

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

By StatLab Medical Products
StatLab Medical Products
25 Jun 2026

The Digital Pharma Advances Conference 2026

Most Popular

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

By TrueMed Ltd.

Jun 08
Strategic Expansion Expands Fusion Orthopedics' Foot & Ankle Reach

By Fusion Orthopedics USA, LLC

Jan 05
FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.

By Bristol Myers Squibb

Sep 27

July 2026

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Avanzanite Bioscience has appointed a new Chief Financial Officer

Spruce Biosciences Reports Long-Term Data Showing Efficacy and Safety of Tralesinidase Alfa in Sanfilippo Syndrome Type B

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

Roche's first respiratory test, powered by TAGS technology, has received FDA clearance for SARS-CoV-2, Influenza A, Influenza B, and RSV

Astellas gets positive CHMP opinion for PADCEV™ and KEYTRUDA® combo in advanced bladder cancer.

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

Nnamdi Njoku Named President of Omnicell

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

Most Popular

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

Strategic Expansion Expands Fusion Orthopedics' Foot & Ankle Reach

FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter